Antitumor mechanism of intradermal administration of lipopolysaccharide

Anticancer Research

Volumn 17, Issue 3 C, 1997, Pages 1961-1964

  Inagawa, Hiroyuki ^a   Nishizawa, Takashi ^a   Takagi, Koichi ^a   Goto, Shigenori ^b   Soma, Gen Ichiro ^a,c   Mizuno, Den'ichi ^d  

^a TAKANO HOSPITAL   (Japan)

^b Kitatama Hospital   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d INSTITUTE OF MICROBIAL CHEMISTRY   (Japan)

Author keywords

Endogenous tumor necrosis factor; Inflammation; Macrophage; Priming effect; Triggering effect

Indexed keywords

LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FIBROSARCOMA; HISTOLOGY; INFLAMMATORY CELL; INJECTION SITE; INTRADERMAL DRUG ADMINISTRATION; LEWIS CARCINOMA; LIVER CELL CARCINOMA; MACROPHAGE; METASTASIS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; ENTEROBACTERIACEAE; FIBROSARCOMA; INFLAMMATION; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; LUNG NEOPLASMS; MICE; NEOPLASM METASTASIS; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030761471     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Mizuno D, Yoshioka O, Akamatu M, et al: Antitumor effect of intracutaneous injection of bacterial lipopolysaccharide. Cancer Res 28: 1531-1537, 1968.
2. Inagawa H, Nishizawa T, Noguchi K, et al: Antitumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system. Anticancer Res in press, 1997.
3. Ohnishi M, Kimura S, Yamazaki M, et al: Antitumor activity of low-toxicity lipopolysaccharide of Bordetella pertusis. Br J Cancer 69: 1037-1042, 1994.
4. Goto S, Sakai S, Kera J, et al: Intradermal administration of lipopolysaccharide in treatment of human cancer. Cancer Immunol Immunother 42: 255-261, 1996.
5. Mizuno D and Soma G-I: Oral or percutaneous administration of lipopolysaccharide of small molecular size may cure various intractable diseases: a new version of Coley's toxin. Mol Biother 4: 166-169, 1992.
6. Mizuno D: Significance of endogenous production of TNF. In: Tumor Necrosis Factor: Structure-function Relationship and Clinical Application. (Osawa T and Bonavida B eds). Basel, Karger, 1992, pp 1-24.
7. Nishizawa T, Okutomi T, Inagawa H, et al. Intratumoral tumor necrosis factor induction in tumor-bearing mice by exogenous/ endogenous tumor necrosis factor therapy as compared with systemic administration of various biologic response modifiers. Mol Biother 3: 224-230, 1991.
8. Nishizawa T, Inagawa H, Oshima H, et al: Homeostasis as regulated by activated macrophage. I. Lipopolysaccharide from wheat flour: Isolation, purification and some biological activities. Chem Pharm Bull 40: 479-483, 1992.
9. Kitahara-Tanabe N, Tanabe Y, Morikawa A, et al. Post-translational processing of tumor necrosis factor production. Chem Pharm Bull 39: 417-420, 1991.
10. Kriegler M, Perez C, DeFay K, et al: A novel form of TNF/cachectin is a cell surface transmembrane protein: Ramifications for the complex physiology of TNF. Cell 53: 45-53, 1988.
11. Klosterggard J, Stoltje PJ and Kull JrFC: Tumoricidal effector mechanisms of murine BCG-activated macrophages: Role of TNF in conjugation-dependent and conjugation independent pathways. J Leuk Biol 48: 220-228, 1990.
12. Klosterggard J, Leroux M and Hung M-C: Cellular models of macrophage tumoricidal effector mechanisms in vitro: characterization of cytolytic responses to tumor necrosis factor and nitric oxide pathways in vitro. J Immunol 147: 2802-2808, 1991.
13. Satoh M, Inagawa H, Minagawa H, et al: Endogenous production of TNF in mice long after BCG sensitization. J Biol Resp Modif 5: 117-123, 1986.
14. Satoh M, Inagawa H, Shimada Y, et al: Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin. J Biol Resp Modif 6: 512-524, 1987.
15. Haranaka K, Satomi N, Sakurai A: Differences in tumor necrosis factor productive ability among rodents, Br J Cancer 50: 471-478, 1984.
16. Inagawa H, Oshima H, Soma G-I, et al: TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF. J Biol Resp Modif 7: 596-607, 1988.
17. Inagawa H, Saitoh F, Iguchi M, et al: Homeostasis as regulated by activated macrophage. V. Protective effect of LPSw (lipopolysaccharide (LPS) of wheat flour) on gastric ulcer in mice as compared with those of other LPS. Chem Pharm Bull 40: 998-1000, 1992.
18. Okutomi T, Nishizawa T, Inagawa H, et al: Inhibition of morphine dependence by a lipopolysaccharide from Pantoea agglomerons. Eur Cytokine Netw 3: 417-420, 1992.